Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00433407
Status:
COMPLETED
Last Update Posted:
2012-10-04
First Post:
2007-02-08
Brief Title:
T-Cell Response in Patients Receiving Trastuzumab andor Chemotherapy for HER2-Positive Solid Tumors
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Jonsson Comprehensive Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unspecified Adult Solid Tumor Protocol Specific |
| Breast Cancer |
| Lung Cancer |
| Ovarian Cancer |
| Prostate Cancer |
| Sarcoma |
Keywords:
| Name | View |
|---|---|
| stage IV non-small cell lung cancer | View |
| recurrent non-small cell lung cancer | View |
| extensive stage small cell lung cancer | View |
| limited stage small cell lung cancer | View |
| recurrent small cell lung cancer | View |
| stage I prostate cancer | View |
| stage IIB prostate cancer | View |
| stage IIA prostate cancer | View |
| stage III prostate cancer | View |
| stage IV prostate cancer | View |
| recurrent prostate cancer | View |
| stage I uterine sarcoma | View |
| stage II uterine sarcoma | View |
| stage III uterine sarcoma | View |
| stage IV uterine sarcoma | View |
| recurrent uterine sarcoma | View |
| unspecified adult solid tumor protocol specific | View |
| stage I breast cancer | View |
| stage II breast cancer | View |
| stage IIIA breast cancer | View |
| stage IIIB breast cancer | View |
| stage IIIC breast cancer | View |
| stage IV breast cancer | View |
| male breast cancer | View |
| recurrent breast cancer | View |
| stage I ovarian epithelial cancer | View |
| stage II ovarian epithelial cancer | View |
| stage III ovarian epithelial cancer | View |
| stage IV ovarian epithelial cancer | View |
| recurrent ovarian epithelial cancer | View |
| stage I non-small cell lung cancer | View |
| stage II non-small cell lung cancer | View |
| stage IIIA non-small cell lung cancer | View |
| stage IIIB non-small cell lung cancer | View |